Literature DB >> 16769449

Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe, Tajikistan, 2004.

Julie A Stachowiak1, Farida K Tishkova, Steffanie A Strathdee, Mark A Stibich, Alisher Latypov, Vladimir Mogilnii, Chris Beyrer.   

Abstract

OBJECTIVE: To examine differences by ethnicity of HIV prevalence and correlates among injection drug users (IDUs) in Dushanbe, Tajikistan.
METHODS: The researchers enrolled 489 active adult IDUs in a cross-sectional risk factor study of HIV infection. Participants were provided HIV pre-and posttest counseling and risk reduction counseling and answered an interviewer-administered questionnaire. HIV-1 status was determined with rapid tests and confirmed with ELISA.
RESULTS: Participants included four ethnicities: 204 Tajiks (49.1%), 145 Russians (29.7%), 58 Uzbeks (11.9%), and 46 participants of other nationalities (9.4%). Overall prevalence of HIV-1 infection was 12% and varied significantly by ethnicity: it was highest among ethnic Tajiks, at 19.2%; lowest among Russians and Uzbeks, at 3.4%; and 13% among other nationalities. Ethnic groups differed significantly in years injecting, receiving a needle from a needle exchange program (NEP), injecting in groups, having undergone drug treatment, reported condom use, and arrest history. Among Tajiks, HIV infection was significantly associated with daily injecting (OR 2.16); reporting that narcotics were very easy to obtain (OR 2.46); having undergone drug treatment (OR 2.75), and injecting "alone" (OR 3.12).
CONCLUSIONS: Ethnic differences were strongly associated with HIV prevalence and risk behaviors in this multiethnic study, and prevention efforts might need to be targeted by ethnicity.

Entities:  

Mesh:

Year:  2006        PMID: 16769449     DOI: 10.1016/s0376-8716(06)80002-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  15 in total

1.  The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan.

Authors:  Nisso Kasymova; Benjamin Johns; Benusrat Sharipova
Journal:  Cost Eff Resour Alloc       Date:  2009-11-03

2.  Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.

Authors:  Alisher Latypov; David Otiashvili; William Zule
Journal:  Int J Drug Policy       Date:  2014-11

3.  Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; M Raza Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Drug Policy       Date:  2010-12-10

4.  Contextual factors influencing HIV risk behaviour in Central Asia.

Authors:  Alex Smolak
Journal:  Cult Health Sex       Date:  2010-06

Review 5.  Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis.

Authors:  Don C Des Jarlais; Azizbek Boltaev; Jonathan Feelemyer; Heidi Bramson; Kamyar Arasteh; Benjamin W Phillips; Holly Hagan
Journal:  Drug Alcohol Depend       Date:  2013-07-25       Impact factor: 4.492

6.  Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan.

Authors:  Chris Beyrer; Zeenat Patel; Julie A Stachowiak; Farida K Tishkova; Mark A Stibich; Lindsay M Eyzaguirre; Jean K Carr; Vladimir Mogilnii; Alena Peryshkina; Alisher Latypov; Steffanie A Strathdee
Journal:  AIDS Res Hum Retroviruses       Date:  2009-09       Impact factor: 2.205

Review 7.  Co-infection with human immunodeficiency virus and tuberculosis in Asia.

Authors:  Sten H Vermund; Naoki Yamamoto
Journal:  Tuberculosis (Edinb)       Date:  2007-07-16       Impact factor: 3.131

8.  Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Authors:  Nino Khetsuriani; Faina Tishkova; Shamsidin Jabirov; Kathleen Wannemuehler; Saleem Kamili; Zulfiya Pirova; Liudmila Mosina; Eugene Gavrilin; Pavel Ursu; Jan Drobeniuc
Journal:  Vaccine       Date:  2015-06-10       Impact factor: 3.641

9.  HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdullah M S Abed; Steffanie A Strathdee; Paul T Scott; Boulos A Botros; Naqibullah Safi; Kenneth C Earhart
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

10.  HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.

Authors:  Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson
Journal:  BMJ Open       Date:  2012-10-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.